Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: A randomized feasibility trial and exploration of the immunomodulatory effects
Open Access
- 1 June 2020
- journal article
- research article
- Published by SAGE Publications in Sage Open Medicine
Abstract
Objectives: Fever control has been shown to reduce short-term mortality in patients with septic shock. This study aimed to explore the feasibility of early intensive fever control in patients with septic shock and to assess the immunomodulatory effects of this intervention. Methods: In this single-center, randomized, open-label trial, febrile patients with septic shock presenting to the emergency department were assigned to either a standard fever control or therapeutic normothermia group. Therapeutic normothermia involved intensive fever control in maintaining normothermia below 37 degrees C. The primary outcome was the feasibility of fever control for 24 h. Secondary outcomes included changes in immunomodulatory biomarkers and adverse events. Results: Fifteen patients were enrolled and analyzed. Fever control was comparable in both groups, but significantly more patients in the therapeutic normothermia group experienced shivering (p = 0.007). Both groups demonstrated increased C-reactive protein and unchanged neutrophil chemotaxis and CD11b expression. The therapeutic normothermia group revealed significant decreased IL-6 and IL-10. The standard fever control group significantly expressed increased monocytic human leukocyte antigen. There were no significant differences between the groups in terms of immunomodulation. Conclusions: Therapeutic normothermia was feasible in patients with febrile septic shock but was not superior to standard fever control in terms of average body temperature and host defense function. Shivering was more frequent in the therapeutic normothermia group.Funding Information
- Chulalongkorn University (CU-59-001-HR)
- Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (RA59/040)
This publication has 40 references indexed in Scilit:
- Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational studyCritical Care, 2012
- C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unitMultidisciplinary Respiratory Medicine, 2012
- Hypothermia and SurgeryAnnals of Surgery, 2009
- Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods*Critical Care Medicine, 2009
- Short-Term Heat Exposure Inhibits Inflammation by Abrogating Recruitment of and Nuclear Factor-κB Activation in Neutrophils Exposed to Chemotactic CytokinesThe American Journal of Pathology, 2008
- Effects of Hypothermia on Mortality and Inflammatory Responses to Endotoxin-Induced Shock in RatsClinical and Vaccine Immunology, 2003
- C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic OptionsThe Journal of Infectious Diseases, 2000
- Effect of Moderate Hypothermia on Systemic and Internal Jugular Plasma IL-6 Levels After Traumatic Brain Injury in HumansJournal of Neurotrauma, 1999
- Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infectionThe Journal of Pediatrics, 1998